FDA Inspection 1180562 — Memorial Hermann Texas Medical Center
The FDA completed an inspection of Memorial Hermann Texas Medical Center on Aug 26, 2022 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 26, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Houston, TX (United States)